NEW YORK, August 17, 2026, 20:10 EDT
- UiPath closed at $15.99, down 0.12%, on 69.9 million shares.
- The stock is up 43.33% over 52 weeks.
- Its price stands about 16% above the $13.80 analyst consensus target.
UiPath Inc. NYSE:PATH barely moved on Monday despite unusually heavy trading. The automation-software stock closed at $15.99, down two cents. Volume reached 69.9 million shares, 8.3% above its three-month average.
The flat finish masks a harder valuation test. UiPath has gained 43.33% over 52 weeks. Monday’s close was 15.9% above the $13.80 average analyst target.
That premium shifts the burden toward execution. The next results must show that agentic automation can sustain growth while protecting margins.
| Monday market comparison | Change | Investor read-through |
|---|---|---|
| UiPath NYSE:PATH | -0.12% | Flat despite elevated volume |
| S&P 500 | -0.52% | Broad market weakened |
| Salesforce NYSE:CRM | -2.67% | Enterprise software lagged |
| Oracle NYSE:ORCL | -2.57% | Software selling persisted |
| ServiceNow NYSE:NOW | -5.08% | Sharpest peer decline |
UiPath opened at $16.66, then lost 4.0% from that level. Yet it outperformed the wider software selloff. The pattern suggests active two-way trading, not a clean risk-on signal.
The operating base has improved. Fiscal first-quarter revenue rose 17% to $418 million. Annual recurring revenue increased 12% to $1.901 billion, while dollar-based net retention reached 109%.
Chief Executive Daniel Dines said agentic products were “moving from pilot to production.” UiPath also posted $28 million of GAAP operating income, reversing a $16 million loss a year earlier. UiPath first-quarter filing
| Operating scorecard | Q1 fiscal 2027 | Year-on-year signal |
|---|---|---|
| Revenue | $418 million | +17% |
| ARR | $1.901 billion | +12% |
| Dollar-based net retention | 109% | Expansion above 100% |
| GAAP operating income | $28 million | Versus $16 million loss |
| Adjusted free cash flow | $130 million | Positive cash generation |
The share price now values UiPath at about 4.7 times the midpoint of fiscal 2027 revenue guidance. Cash and marketable securities equal roughly 17% of market value. Those figures offer support, but they do not erase the expectations gap.
| Valuation bridge | Value | Calculation |
|---|---|---|
| Market capitalization | $8.285 billion | Monday market data |
| Fiscal 2027 revenue midpoint | $1.779 billion | Company guidance |
| Price-to-guided-sales | 4.7x | Market cap / revenue midpoint |
| Cash and securities | $1.42 billion | April 30 balance |
| Cash as share of market cap | 17.1% | Cash / market cap |
Wall Street remains cautious. MarketBeat’s 17-analyst tally shows two buys, 14 holds and one sell. Its $13.80 average target implies 13.7% downside from Monday’s close.
| Firm | Latest stance | Target | Date |
|---|---|---|---|
| UBS | Hold | $12 | June 29, 2026 |
| BMO Capital Markets | Market Perform | $13 | June 1, 2026 |
| DA Davidson | Neutral | $12 | May 29, 2026 |
| Bank of America | Underperform | $13 | May 29, 2026 |
| Morgan Stanley | Equal Weight | $15 | May 29, 2026 |
| Needham | Buy | $15 | May 29, 2026 |
The next checkpoint is fiscal second-quarter performance. UiPath guided revenue to $395 million to $400 million. It forecast ARR of $1.929 billion to $1.934 billion and about $75 million of non-GAAP operating income.
Full-year guidance calls for $1.776 billion to $1.781 billion of revenue. The implied non-GAAP operating margin is about 24.2%. Delivering that margin while ARR growth accelerates would help justify the premium.
Risks: Enterprise software budgets can lengthen without warning. Agentic AI adoption may also move more slowly than pilots suggest. A weak retention reading or softer guidance would expose the stock’s analyst-target premium.
Monday’s resilience was notable. It was not decisive. Investors now need operating proof to turn heavy trading into durable upside.
Related articles: NYSE:PATH
